Moving Towards Accountability for Reasonableness – A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study

Author:

Wagner Monika1ORCID,Samaha Dima2,Casciano Roman3,Brougham Matthew1,Abrishami Payam4ORCID,Petrie Charles5,Avouac Bernard6,Mantovani Lorenzo7,Sarría-Santamera Antonio89ORCID,Kind Paul10,Schlander Michael1112,Tringali Michele13

Affiliation:

1. Analytica Laser, Montreal, QC, Canada.

2. Analytica Laser, London, UK.

3. Analytica Laser, New York City, NY, USA.

4. National Health Care Institute (ZIN), Diemen, The Netherlands.

5. Pfizer Inc, New York City, NY, USA (retired).

6. Liège University, Liège, Belgium.

7. Center for Public Health Research, University of Milan-Bicocca, Milan, Italy.

8. National School of Public Health IMIENS-UNED, Madrid, Spain.

9. Department of Public Health, University of Alcalá, Alcalá de Henares, Spain.

10. University of Leeds, Leeds, UK.

11. Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

12. University of Heidelberg, Heidelberg, Germany.

13. ASST Niguarda and Regione Lombardia, Welfare Directorate, Milano, Italy.

Abstract

Background: The accountability for reasonableness (A4R) framework defines 4 conditions for legitimate healthcare coverage decision processes: Relevance, Publicity, Appeals, and Enforcement. The aim of this study was to reflect on how the diverse features of decision-making processes can be aligned with A4R conditions to guide decision-making towards legitimacy. Rare disease and regenerative therapies (RDRTs) pose special decision-making challenges and offer therefore a useful case study. Methods: Features operationalizing each A4R condition as well as three different approaches to address these features (cost-per-QALY-focused and multicriteria-based) were defined and organized into a matrix. Seven experts explored these features during a panel run under the Chatham House Rule and provided general and RDRT-specific recommendations. Responses were analyzed to identify converging and diverging recommendations. Results: Regarding Relevance, recommendations included supporting deliberation, stakeholder participation and grounding coverage decision criteria in normative and societal objectives. Thirteen of 17 proposed decision criteria were recommended by a majority of panelists. The usefulness of universal cost-effectiveness thresholds to inform allocative efficiency was challenged, particularly in the RDRT context. RDRTs raise specific issues that need to be considered; however, rarity should be viewed in relation to other aspects, such as disease severity and budget impact. Regarding Publicity, panelists recommended transparency about the values underlying a decision and value judgements used in selecting evidence. For Appeals, recommendations included a life-cycle approach with clear provisions for re-evaluations. For Enforcement, external quality reviews of decisions were recommended. Conclusion: Moving coverage decision-making processes towards enhanced legitimacy in general and in the RDRT context involves designing and refining approaches to support participation and deliberation, enhancing transparency, and allowing explicit consideration of multiple decision criteria that reflect normative and societal objectives.

Publisher

Maad Rayan Publishing Company

Subject

Health Policy,Health Information Management,Leadership and Management,Management, Monitoring, Policy and Law,Health (social science)

Reference91 articles.

1. Definition of legitimacy in English by Oxford Dictionaries. English Oxford Dictionary website. https://en.oxforddictionaries.com/definition/legitimacy. Updated 2018.

2. Terwindt F, Rajan D, Soucat A. Priority-setting for national health policies, strategies and plans. In: Strategizing national health in the 21st century: a handbook. World Health Organization; 2016.

3. Social values in health priority setting: a conceptual framework

4. Justice, Health, and Healthcare

5. The art of priority setting

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3